A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer

Clinical trial NCT01000480 · COMPLETED

Trial details

NCT number: NCT01000480
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2009-10-01
Primary completion: 2013-01-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.